To determine the molecular basis for the observed UBASH3A downregulation in RA patients, we assessed the activity of UBASH3A-SE, because SEs are prime regions governing the transcription of adjacent genes. The gene discussed is UBASH3A; the disease is rheumatoid arthritis.